Publications

Journal of Medicinal Chemistry

 Zotchev SB, Stepanchikova AV, Sergeyko AP, Sobolev BN, Filimonov DA, Poroikov VV
 Journal of Medicinal Chemistry - vol. 49 2077-2087 (2006)

Bacterial secondary metabolites display diverse biological activities, thus having potential as pharmacological agents. Although most of these compounds are discovered by random screening, it is possible to predict and re-design their structures based on the information on their biosynthetic pathways. Biosynthesis of macrolides, governed by modular polyketide synthases (PKS), obeys certain rules, which can be […]

Publications
Journal of Physiology-Paris

 Shimahara T
 Journal of Physiology-Paris - vol. 99 73-74 (2006)

Drug Discovery Today: Technologies

 Fara DC, Oprea TI, Prossnitz ER, Bologa CG, Edwards BS, Sklar LA
 Drug Discovery Today: Technologies - vol. 3 377-385 (2006)

High-throughput screening (HTS) represents the dominant technique for the identification of new lead compounds in current drug discovery. It consists of physical screening (PS) of large libraries of chemicals against one or more specific biological targets. Virtual screening (VS) is a strategy for in silico evaluation of chemical libraries for a given target, and can […]

Nethods in Molecular Biology

 Tobergte DR, Curtis S
 Nethods in Molecular Biology - vol. Second Edi 17-25 (2005)

applicability for this approach.

Proceedings of the National Academy of Sciences of the United States of America

 Ray SS, Nowak RJ, Brown RH, Lansbury PT
 Proceedings of the National Academy of Sciences of the United States of America - vol. 102 3639-3644 (2005)

Familial amyotrophic lateral sclerosis (FALS) is a fatal motor neuron disease that is caused by mutations in the gene encoding superoxide dismutase-type 1 (SOD1). The affected regions of the FALS brain are characterized by aggregated SOD1, and the mutations that destabilize SOD1 appear to promote its aggregation in vitro. Because dissociation of the native SOD1 […]

Nat Rev Drug Discov

 O'Connor KA, Roth BL
 Nat Rev Drug Discov - vol. 4 1005-1014 (2005)

With the annotation of the human genome approaching completion, public-sector researchers – spurred in part by various National Institutes of Health Roadmap Initiatives – have become increasingly engaged in drug discovery and development efforts. Although large and diverse chemical libraries of ‘drug-like’ compounds can be readily screened to yield chemically novel scaffolds, transforming these ‘chemical […]

Antimicrobial Agents and Chemotherapy

 Razonable RR, Henault M, Watson HL, Paya CV
 Antimicrobial Agents and Chemotherapy - vol. 49 3546-3549 (2005)

Nystatin is an antifungal compound with potent proinflammatory properties. Herein, we demonstrate that nystatin induces interleukin (IL)-1beta, IL-8, and tumor necrosis factor alpha secretion through its activation of toll-like receptor 1 (TLR1) and TLR2. Hence, a TLR-dependent mechanism could serve as the molecular basis for the proinflammatory properties of nystatin.

Chemistry and Biology

 Rao FV, Andersen OA, Vora KA, DeMartino JA, Van Aalten DMF
 Chemistry and Biology - vol. 12 973-980 (2005)

Family 18 chitinases play key roles in a range of pathogenic organisms and are overexpressed in the asthmatic lung. By screening a library of marketed drug molecules, we have identified methylxanthine derivatives as possible inhibitor leads. These derivatives, theophylline, caffeine, and pentoxifylline, are used therapeutically as antiinflammatory agents, with pleiotropic mechanisms of action. Here it […]

All our screening libraries

Partners